Sanxiang***, December 25 (Quan**Reporter Pan Xianxuan) Today, Hunan Province held the second New Hunan Contribution Award and the 2023 Sanxiang Top 100 Private Enterprises Press Conference in Changsha, at which the 2023 Sanxiang Top 100 Private Enterprises list and analysis report were released, and Hunan Hengchang Pharmaceutical Group successfully ranked among the 2023 Sanxiang Top 100 Private Enterprises.
It is understood that the overall scale of the top 100 private enterprises in Sanxiang in 2023 will continue to increase, and the total operating income and total assets will continue to grow, both exceeding one trillion yuan. The total operating income was 110261.2 billion yuan, an increase of 245 over the previous year900 million yuan, an increase of 228%；Total assets are 11,3053.5 billion yuan, an increase of 174 over the previous year3.3 billion yuan, an increase of 157%。
Hengchang Pharmaceutical is a pharmaceutical distribution enterprise serving small and medium-sized chain pharmacies, single pharmacies and primary medical and health institutions. In recent years, Hengchang Pharmaceutical has developed rapidly with its "direct supply and exclusive sales" business model, and submitted an IPO application to the Shenzhen Stock Exchange in 2022. According to the prospectus, Hengchang Pharmaceutical's main business income in 2022 will be nearly 3 billion yuan, and the tax amount will be 23.2 billion yuan, the sales scale continued to grow rapidly.
The threshold for the top 100 list has reached a new high, from 21 in the previous year9 billion yuan rose to 277.5 billion yuan, an increase of 2671%。This is also the first time that Hengchang Pharmaceutical has entered the list of top 100 private enterprises in Hunan.
At the press conference, the winners of the 2nd New Hunan Contribution Award were also released. Jiang Jin, chairman of Hengchang Pharmaceutical, has won the title of advanced individual in the first New Hunan Contribution Award, and will be rated as "Changsha High-level Talent (Class B)" by the Changsha Municipal Party Committee in 2023.
In addition, Hengchang Pharmaceutical has taken the initiative to fulfill its social responsibilities and actively participated in philanthropy in recent years, and has won the 2020 "Special Contribution Award of the Red Cross Society of China for the Prevention and Control of the New Coronary Pneumonia Epidemic Prevention and Control Award", "Hunan Province Epidemic Prevention and Control Outstanding Contribution Enterprise", "Hunan Charity Award Most Caring Donation Enterprise" and other honors, and was listed in the "2021 Changsha Charity Unit Donation List" and "2021 Changsha Charity Enterprise Influence List".